-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Tomson By-Health plans to invest in Danlu enterprise in Ganzhou
Tomson By-Health Co.
, Ltd.
recently issued an announcement that the company signed an agreement with relevant partners to use its own funds of 30 million yuan to invest in Ganzhou Danlu Health Investment Partnership (Limited Partnership).
Ganzhou Danlu subsequently signed a relevant agreement to invest 130 million yuan in Guangzhou Kechuang Danlu Phase III Venture Capital Fund Partnership (Limited Partnership).
The company's investment aims to achieve a better return on investment by investing in start-up, early-stage enterprises or high-quality projects with the help of the resources and capabilities of professional investment
institutions.
Yibaoxin was successfully listed on the new third board
Zhejiang Ebaoxin Biotechnology Co.
, Ltd
.
(hereinafter referred to as "Ebaoxin") has been successfully listed on the New Third Board.
"The company will leverage the capital market platform to accelerate development, rely on science and technology to continue to leapfrog, and strive to become a world-class natural vitamin E supplier in terms of scale, variety and quality, and achieve the goal
of listing on the Beijing Stock Exchange as soon as possible.
" Huang Maoqing, chairman and general manager of Yibaoxin, said
.
In recent years, Eboxin has maintained a steady growth trend, and the revenue of the company's core products natural vitamin E and plant sterols has continued to grow
.
In 2021, the company achieved revenue of 196 million yuan, an increase of 28.
65% over 152 million yuan in 2020; The net profit was 12.
3204 million yuan, a year-on-year increase of 17.
39%.
Xiwang Food plans to launch a variety of health foods
Xiwang Food Co.
, Ltd.
recently said that according to business development, the company will launch new products from time to time to meet the needs of
consumers.
In the near future, the company plans to launch a variety of health foods
represented by Pure Inspired in China.
(Compiled by Zhu Meiqiao)
China Food News(November 30, 2022, Version 06)
(Responsible editor: Zhu Meiqiao)
